Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Business & Regulation Advanced Medicine

C&G Therapy? That’ll Do NICEly

| James Strachan

The striking combination of remarkable, long-lasting, clinical effectiveness and a hefty price tag presents a real challenge to health technology assessors considering cell and gene therapies. Nick Crabb explains how the UK’s health technology assessment agency, NICE, is tackling the problem.

Discovery & Development Advanced Medicine

Perusing the Pipeline

| James Strachan

With cell and gene therapies being all the rage, we take a peek at some of the advanced therapies coming down the pipe – from preclinical studies through to phase III trials.

Business & Regulation Quality & Compliance

Animal-Free; Risk-Free

| Aaron Schieving

If you or your supplier are working with animal-derived components, you run the risk of exposing patients to dangerous contaminations.

Register to personalize your newsfeed

Create Account

Latest Articles

Discovery & Development Analytical Science

The Color of Chirality

| Maryam Mahdi

Forty years ago, it was theorized that chirality had a color composition that could be measured… and finally the theory has been proven.

Manufacture Packaging

Packaging for All

| Stephen Wilkins

When considering the elderly, we can’t stop at drug development – packaging needs special consideration too.

Discovery & Development Analytical Science

At the Cutting-Edge of Pharma Analytics

Meet the analytical experts working at the cutting-edge of pharma analytics to ensure the safety of medicines.

Discovery & Development Clinical Trials

With Age Comes Challenges But Not Trials

| Maryam Mahdi, Stephanie Sutton

A key focus of Andrew McLachlan’s career is understanding the impact of aging on drug disposition and response to medicines.

Business & Regulation Trends & Forecasts

Ask, and Ye Shall Receive

| James Strachan

Regardless of how Britain leaves the European Union, the global pharma industry must always lobby for positive change.

Manufacture Contract Manufacturing Services

Phasing Out Inefficiency

| Simon Tyler

Struggling with process research and development? Find yourself a CRO that knows what it’s doing.

Discovery & Development Drug Delivery

The Elderly Are the Future

| Erin O’Brien, Chris Evans

Drug delivery devices must take into account the needs of older adults.

Discovery & Development Formulation

In Conversation with Dr. Martin Klatt of BASF

The Medicine Maker speaks with Dr. Martin Klatt, Director Sales Pharma Solutions Europe from BASF

Discovery & Development Formulation

Taste the Rainbow

| Nicolas Madit

The color of a capsule or tablet can have a big impact on compliance and branding. To avoid delays, early decisions have to be made.

Discovery & Development Small Molecules

Solutions in... Drug Development

| James Strachan

Douglas J. Swirsky, CEO of Rexahn Pharmaceuticals, explains his company’s approach to developing more effective cancer treatments.

All Articles

Upcoming Events

-

DCAT

New York, USA

CAT Week ‘19: Business Development | Networking | Industry Education
DCAT Week is the premier business development...

-

INTERPHEX 2019 – Register Now!

New York City, USA

State-of-the-Art Solutions to Cost Effectively Develop and Manufacture Quality Product. INTERPHEX is the premier pharma,...

-

Making Pharmaceuticals: the UK’s leading Exhibition and Conference for Pharmaceutical Professionals

Coventry, Uk

On April 30th and May 1st at the RICOH Arena Coventry, Making Pharmaceuticals will host over 2,000 visiting pharma...

All Events

Sister Publications

You might be interested in our Sister Publications:


Latest White Papers

Technology for combating counterfeit medicine

| Contributed by Malvern Panalytical

All White Papers

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register